iSERA Lifesciences Allots 1.61 Crore Shares To Acquire Biological

Board allotted 1,61,82,800 shares at Rs48.20 via 1:1 swap to 196 iSERA Biological holders for 100% acquisition. Paid-up rises to 2,45,91,772 shares from 84,08,972. Closes core strategic pivot from micro IT shell to pharma/biotech control; first large premium swap after par rights issue. Had postal-ballot and BSE in-principle approvals. New holders take ~66% with Biological as subsidiary; control consolidates with Garad/Kadam/Yadav group. Listing approvals, revised name-change cert and Q1/Q2 results pending.